4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors
A Standard patent application filed on 19 November 2003 credited to Dube, Daniel ; Macdonald, Dwight ; Dube, Laurence ; Girard, Yves ; Lacombe, Patrick ; Aspiotis, Renee ; Gallant, Michel

Details

Application number :

2003283167  

Application type :

Standard  

Application status :

SEALED  

Under opposition :

No  

Proceeding type :

 

Invention title :

4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors  

Inventor :

Dube, Daniel ; Macdonald, Dwight ; Dube, Laurence ; Girard, Yves ; Lacombe, Patrick ; Aspiotis, Renee ; Gallant, Michel  

Agent name :

Spruson & Ferguson  

Address for service :

Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 Australia  

Filing date :

19 November 2003  

Associated companies :

 

Applicant name :

Merck Frosst Canada Ltd.  

Applicant address :

16711 Trans-Canada Highway Kirkland Quebec H9H 3L1 Canada  

Old name :

Merck Frosst Canada & Co.  

Original Source :

Go